Found 2 results
Filters: Author is B. Cui  [Clear All Filters]
H. Y. Jia, Zhang, Z. G., Gu, X. J., Guo, T., Cui, B., Ning, G., and Zhao, Y. J., Association between interleukin 21 and Graves’ disease, vol. 10, pp. 3338-3346, 2011.
Bahn RS (1995). Assessment and management of the patient with Graves' ophthalmopathy. Endocr. Pract. 1: 172-178. PMid:15251590   Ban Y and Tomer Y (2003). The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity 36: 367-379. PMid:14669944   Barrett JC, Fry B, Maller J and Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. PMid:15297300   Bednarczuk T, Gopinath B, Ploski R and Wall JR (2007). Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin. Endocrinol. 67: 3-19. PMid:17521325   Caprioli F, Sarra M, Caruso R, Stolfi C, et al. (2008). Autocrine regulation of IL-21 production in human T lymphocytes. J. Immunol. 180: 1800-1807. PMid:18209077   Caruso R, Fina D, Peluso I, Fantini MC, et al. (2007). IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis. J. Immunol. 178: 5957-5965. PMid:17442980   Chen RH, Chen WC, Chang CT, Tsai CH, et al. (2005). Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease. J. Clin. Lab. Anal. 19: 133-138. PMid:16025481   Davis ID, Skak K, Smyth MJ, Kristjansen PE, et al. (2007). Interleukin-21 signaling: functions in cancer and autoimmunity. Clin. Cancer Res. 13: 6926-6932. PMid:18056166   Farid NR and Balazs C (1998). The genetics of thyroid associated ophthalmopathy. Thyroid 8: 407-409. PMid:9623731   Hiromatsu Y, Kaku H, Miyake I, Murayama S, et al. (2002). Role of cytokines in the pathogenesis of thyroid-associated ophthalmopathy. Thyroid 12: 217-221. PMid:11952042   Hiromatsu Y, Mukai T, Kaku H, Miyake I, et al. (2006). IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease. Diabet. Med. 23: 211-215. PMid:16433722   Kasaian MT, Whitters MJ, Carter LL, Lowe LD, et al. (2002). IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16: 559-569.   Leonard WJ and Spolski R (2005). Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5: 688-698. PMid:16138102   Liang J, Chen P, Hu Z, Zhou X, et al. (2008). Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis 29: 2341-2346. PMid:18845558   Lin MC, Hsu FM, Bee YS and Ger LP (2008). Age influences the severity of Graves' ophthalmopathy. Kaohsiung J. Med. Sci. 24: 283-288.   Liu R, Van KL, La CA, Price M, et al. (2006). Autoreactive T cells mediate NK cell degeneration in autoimmune disease. J. Immunol. 176: 5247-5254. PMid:16621990   Liu Y, Helms C, Liao W, Zaba LC, et al. (2008). A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 4: e1000041. PMid:18369459 PMCid:2274885   Mehta DS, Wurster AL and Grusby MJ (2004). Biology of IL-21 and the IL-21 receptor. Immunol. Rev. 202: 84-95. PMid:15546387   Meller J, Jauho A, Hufner M, Gratz S, et al. (2000). Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay. Thyroid 10: 1073-1079. PMid:11201852   Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, et al. (1989). Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br. J. Ophthalmol. 73: 639-644. PMid:2765444 PMCid:1041835   Ozaki K, Spolski R, Feng CG, Qi CF, et al. (2002). A critical role for IL-21 in regulating immunoglobulin production. Science 298: 1630-1634. PMid:12446913   Parrish-Novak J, Dillon SR, Nelson A, Hammond A, et al. (2000). Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63. PMid:11081504   Piao WH, Jee YH, Liu RL, Coons SW, et al. (2008). IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis. Scand. J. Immunol. 67: 37-46. PMid:18052963   Solé X, Guinó E, Valls J, Iniesta R, et al. (2006). SNPStats: a web tool for the analysis of association studies. Bioinformatics 22: 1928-1929. PMid:16720584   Spolski R and Leonard WJ (2008a). Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26: 57-79. PMid:17953510   Spolski R and Leonard WJ (2008b). The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr. Opin. Immunol. 20: 295-301. PMid:18554883 PMCid:2546604   Strengell M, Matikainen S, Siren J, Lehtonen A, et al. (2003). IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J. Immunol. 170: 5464-5469. PMid:12759422   Vollmer TL, Liu R, Price M, Rhodes S, et al. (2005). Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J. Immunol. 174: 2696-2701. PMid:15728477   Wall JR, Salvi M, Bernard NF, Boucher A, et al. (1991). Thyroid-associated ophthalmopathy - a model for the association of organ-specific autoimmune disorders. Immunol. Today 12: 150-153. PMid:1878126   Weetman AP, Cohen S, Gatter KC, Fells P, et al. (1989). Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin. Exp. Immunol. 75: 222-227. PMid:2784734 PMCid:1542121   Yamada M, Li AW and Wall JR (2000). Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management. Crit. Rev. Clin. Lab. Sci. 37: 523-549. PMid:11192331
Z. Wang, Yao, H., Cui, B., Ning, G., and Tang, G. Y., Genetic linkage analysis of oral lichen planus in a Chinese family, vol. 10, pp. 1427-1433, 2011.
Axéll T and Rundquist L (1987). Oral lichen planus - a demographic study. Community Dent. Oral Epidemiol. 15: 52-56. doi:10.1111/j.1600-0528.1987.tb00480.x PMid:3467894 Bai J, Jiang L, Lin M, Zeng X, et al. (2009). Association of polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes with oral lichen planus: a study in a Chinese cohort with Han ethnicity. J. Interferon Cytokine Res. 29: 381-388. doi:10.1089/jir.2008.0089 Bermejo-Fenoll A and Lopez-Jornet P (2006). Familial oral lichen planus: presentation of six families. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 102: e12-e15. doi:10.1016/j.tripleo.2006.03.016 PMid:16876038 Camisa C and Popovsky JL (2000). Effective treatment of oral erosive lichen planus with thalidomide. Arch. Dermatol. 136: 1442-1443. doi:10.1001/archderm.136.12.1442 PMid:11115153 Chaiyarit P, Kafrawy AH, Miles DA, Zunt SL, et al. (1999). Oral lichen planus: an immunohistochemical study of heat shock proteins (HSPs) and cytokeratins (CKs) and a unifying hypothesis of pathogenesis. J. Oral Pathol. Med. 28: 210-215. doi:10.1111/j.1600-0714.1999.tb02026.x Dan H, Liu W, Zhou Y, Wang J, et al. (2010). Association of interleukin-8 gene polymorphisms and haplotypes with oral lichen planus in a Chinese population. Inflammation 33: 76-81. doi:10.1007/s10753-009-9160-0 PMid:19842025 Fujita H, Kobayashi T, Tai H, Nagata M, et al. (2009). Assessment of 14 functional gene polymorphisms in Japanese patients with oral lichen planus: a pilot case-control study. Int. J. Oral Maxillofac. Surg. 38: 978-983. doi:10.1016/j.ijom.2009.05.001 PMid:19497711 Jungell P (1991). Oral lichen planus. A review. Int. J. Oral Maxillofac. Surg. 20: 129-135. doi:10.1016/S0901-5027(05)80001-3 Liu W, Dan H, Wang Z, Jiang L, et al. (2009). IFN-gamma and IL-4 in saliva of patients with oral lichen planus: a study in an ethnic Chinese population. Inflammation 32: 176-181. doi:10.1007/s10753-009-9118-2 PMid:19370405 Lozada-Nur F and Miranda C (1997). Oral lichen planus: epidemiology, clinical characteristics, and associated diseases. Semin. Cutan. Med. Surg. 16: 273-277. doi:10.1016/S1085-5629(97)80016-8 Petropoulou H, Kontochristopoulos G, Kalogirou O, Panteri I, et al. (2006). Effective treatment of erosive lichen planus with thalidomide and topical tacrolimus. Int. J. Dermatol. 45: 1244-1245. doi:10.1111/j.1365-4632.2006.02949.x PMid:17040454 Scardina GA, Ruggieri A, Messina P and Maresi E (2009). Angiogenesis of oral lichen planus: a possible pathogenetic mechanism. Med. Oral Patol. Oral Cir. Bucal. 14: e558-e562. doi:10.4317/medoral.14.e558 Silverman S Jr and Bahl S (1997). Oral lichen planus update: clinical characteristics, treatment responses, and malignant transformation. Am. J. Dent. 10: 259-263. PMid:9590911 Sklavounou-Andrikopoulou A, Chrysomali E, Iakovou M, Garinis GA, et al. (2004). Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus. J. Oral Pathol. Med. 33: 386-390. doi:10.1111/j.1600-0714.2004.00221.x PMid:15250829 Sugerman PB, Satterwhite K and Bigby M (2000). Autocytotoxic T-cell clones in lichen planus. Br. J. Dermatol. 142: 449-456. doi:10.1046/j.1365-2133.2000.03355.x PMid:10735949 Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, et al. (2002). The pathogenesis of oral lichen planus. Crit. Rev. Oral Biol. Med. 13: 350-365. doi:10.1177/154411130201300405 van der Meij EH, Mast H and van der Waal I (2007). The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol. 43: 742-748. doi:10.1016/j.oraloncology.2006.09.006 PMid:17112770 Vincent SD, Fotos PG, Baker KA and Williams TP (1990). Oral lichen planus: the clinical, historical, and therapeutic features of 100 cases. Oral Surg. Oral Med. Oral Pathol. 70: 165-171. doi:10.1016/0030-4220(90)90112-6 Wilson E (1869). On lichen planus. J. Cutan. Med. Dis. Skin. 3: 117-132.